Drug Profile
GEO MM01
Alternative Names: GEO-MM01Latest Information Update: 19 Feb 2024
Price :
$50
*
At a glance
- Originator GeoVax Labs
- Developer Burnet Institute; GeoVax Labs
- Class Malaria vaccines; Viral vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Marburg virus disease
- No development reported Malaria
Most Recent Events
- 13 Feb 2024 GeoVax Labs has patent protection for Replication-Deficient Modified Vaccinia Ankara (MVA) Expressing Marburg Virus Glycoprotein (GP) and Matrix Protein (VP40)in USA
- 09 Oct 2023 GeoVax Labs receives patent allowance for GEO MM01 in USA
- 28 Jun 2023 No recent reports of development identified for preclinical development in Malaria(Prevention) in USA (Parenteral)